National Research Corporation to Issue Quarterly Dividend of $0.12 (NASDAQ:NRC)

Key Points

• National Research Corporation announced a quarterly dividend of $0.12 per share, with shareholders on record to receive payments on October 10th, representing an annualized dividend of $0.48 and a yield of 3.62%.
• The company's stock price decreased by 4.9%, closing at $13.26, with a market capitalization of $302.06 million and a P/E ratio of 12.87.
• Recent institutional trading showed increased interest, with notable investments from organizations like Jane Street Group LLC, which raised its stake by 394.2%.

National Research Corporation (NASDAQ:NRC - Get Free Report) declared a quarterly dividend on Tuesday, July 29th, Wall Street Journal reports. Shareholders of record on Friday, September 26th will be paid a dividend of 0.12 per share on Friday, October 10th. This represents a $0.48 dividend on an annualized basis and a yield of 3.62%. The ex-dividend date of this dividend is Friday, September 26th.

National Research Stock Down 4.9%

NRC traded down $0.68 during trading on Tuesday, reaching $13.26. The company had a trading volume of 137,556 shares, compared to its average volume of 90,802. The company has a debt-to-equity ratio of 1.98, a current ratio of 0.54 and a quick ratio of 0.54. National Research has a 12 month low of $9.76 and a 12 month high of $27.07. The business's fifty day moving average price is $15.35 and its 200 day moving average price is $14.73. The company has a market cap of $302.06 million, a P/E ratio of 12.87 and a beta of 0.45.

National Research (NASDAQ:NRC - Get Free Report) last announced its quarterly earnings results on Monday, July 28th. The company reported $0.28 earnings per share for the quarter. The firm had revenue of $34.04 million for the quarter. National Research had a net margin of 17.14% and a return on equity of 71.33%.

Insider Activity at National Research

In other National Research news, major shareholder Patrick E. Beans acquired 2,500 shares of the business's stock in a transaction dated Monday, May 12th. The shares were acquired at an average price of $13.59 per share, with a total value of $33,975.00. Following the completion of the transaction, the insider directly owned 35,003 shares in the company, valued at $475,690.77. This trade represents a 7.69% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Institutional Trading of National Research

Institutional investors have recently made changes to their positions in the business. Strs Ohio bought a new stake in shares of National Research in the first quarter worth $33,000. Cubist Systematic Strategies LLC bought a new stake in shares of National Research in the first quarter worth $118,000. Jane Street Group LLC lifted its position in shares of National Research by 394.2% in the first quarter. Jane Street Group LLC now owns 52,411 shares of the company's stock worth $671,000 after purchasing an additional 41,806 shares in the last quarter. Finally, AQR Capital Management LLC lifted its position in shares of National Research by 168.6% in the first quarter. AQR Capital Management LLC now owns 108,134 shares of the company's stock worth $1,384,000 after purchasing an additional 67,882 shares in the last quarter. Institutional investors own 47.26% of the company's stock.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.